Vontobel Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-322,806
Closed -$33.5M 75
2015
Q1
$33.5M Sell
322,806
-439,642
-58% -$46.8M 0.25% 46
2014
Q4
$89.8M Sell
762,448
-1,149,661
-60% -$151M 0.73% 36
2014
Q3
$281M Buy
1,912,109
+96,217
+5% +$14.9M 2.19% 15
2014
Q2
$300M Buy
1,815,892
+827,685
+84% +$147M 3.03% 11
2014
Q1
$194M Sell
988,207
-155,040
-14% -$29.3M 2.25% 15
2013
Q4
$215M Sell
1,143,247
-586,594
-34% -$109M 2.5% 10
2013
Q3
$288M Sell
1,729,841
-135,958
-7% -$21.1M 3.98% 7
2013
Q2
$281M Buy
+1,865,799
New +$264M 3.61% 7

Other funds holding CLB

Vontobel Asset Management's CLB Position: Q2 2015 in Review

Vontobel Asset Management sold out of Core Laboratories (CLB) in Q2 2015, closing a stake of 322,806 shares — an estimated $33.5M sold.

Vontobel Asset Management first reported a position in CLB in Q2 2013 and held it in 8 quarters. The position peaked at $300M in Q2 2014. 357 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

  • Vontobel Asset Management reported no remaining Core Laboratories position as of Q2 2015 after selling out during the quarter.
  • Vontobel Asset Management sold 322,806 Core Laboratories shares in Q2 2015, an estimated $33.5M.
  • Vontobel Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 8 quarters.
  • Vontobel Asset Management's Core Laboratories position peaked at $300M in Q2 2014.
  • 357 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on Vontobel Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.